The OBR Video Center Features educational videos covering a wide range of oncology specific topics.
Dr. Mittendorf, Director of the Breast Immuno-Oncology Program, Dana-Farber/Brigham and Women’s Cancer Center, Rob and Karen Hale Distinguished Chair, discusses the outcomes of the IMpassion-031 study investigating the neoadjuvant use of atezolizumab plus chemotherapy in early triple-negative breast cancer (TNBC)
Published: 01 October 2020
Thomas J. George, MD, regarding the NRG-GI002 trial as presented at ASCO GI 2021
Dr. George, Director, GI Oncology Program, University of Florida, discusses primary results from the NRG-GI002 trial as presented at the ...
Zev Wainberg, MD, elaborates on outcomes from the FIGHT trial as presented at ASCO GI 2021
Dr. Wainberg, Co-Director, UCLA GI Oncology Program, Medical Director, UCLA Colorectal Cancer Center, Assistant Professor of Medicine, Division of Hematology ...
Thomas J. George, MD, elaborates on the design of the NRG-GI002 clinical trial
Dr. George, Director, GI Oncology Program, University of Florida, elaborates on the design of the NRG-GI002 clinical trial
Zev Wainberg, MD, discusses the safety profile of bemarituzumab
Dr. Wainberg, Co-Director, UCLA GI Oncology Program, Medical Director, UCLA Colorectal Cancer Center, Assistant Professor of Medicine, Division of Hematology ...
Thomas J. George, MD, considers results from the experimental arms of the NRG-GI002 clinical trial
Dr. George, Director, GI Oncology Program, University of Florida, considers results from the experimental arms of the NRG-GI002 clinical trial
Zev Wainberg, MD, speculates on the role of bemarituzumab in other FGFR2b-positive tumor types
Dr. Wainberg, Co-Director, UCLA GI Oncology Program, Medical Director, UCLA Colorectal Cancer Center, Assistant Professor of Medicine, Division of Hematology ...
Thomas J. George, MD, discusses the side effect profile of pembrolizumab in the NRG-GI002 trial
Dr. George, Director, GI Oncology Program, University of Florida, discusses the side effect profile of pembrolizumab in the NRG-GI002 trial ...
Zev Wainberg, MD, considers the influence of ctDNA testing in the treatment of gastric cancer
Dr. Wainberg, Co-Director, UCLA GI Oncology Program, Medical Director, UCLA Colorectal Cancer Center, Assistant Professor of Medicine, Division of Hematology ...
Thomas J. George, MD, on the evolving treatment landscape of locally advanced rectal cancer
Dr. George, Director, GI Oncology Program, University of Florida, speculates on the evolving treatment landscape of locally advanced rectal cancer ...
Rachna Shroff, MD, tells us about the NuTide:121 trial as presented at GI 2021
Dr. Shroff, Medical Director, Clinical Trials Office, Chief, Section of GI Medical Oncology, University of Arizona Cancer Center, tells us ...
Follow @OBRTweets